Michael Minogue

Track

Insider profile

Currently holds positions in ABIOMED Inc and Insulet Corp

Performance

Overall performance
1.2
Performance over holding periods
1.2
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, President, Chief Executive Officer ABIOMED Inc June 10, 2005 -
Independent Director Insulet Corp Aug. 9, 2017 -
Michael Minogue's trades of Insulet Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-26 2026-02-25
US Insulet Corp (PODD)
B Purchase
12,406 +15.3%
457.09
US$134,670 		12,406 +15.3% 457.09 US$134,670
2023-05-24 2023-05-23
US Insulet Corp (PODD)
B Purchase
3,475 -8.8%
434.29
US$2,585,220 		3,475 -8.8% 434.29 US$2,585,220
2021-06-23 2021-06-21
US ABIOMED Inc (ABMD)
PlS Planned sale
5,470 -23.3%
426.63
US$3,768,106 		5,470 -23.3% 426.63 US$3,768,106
2021-06-23 2021-06-21
US ABIOMED Inc (ABMD)
PlS Planned sale
19,657 -8.3%
325.16
US$6,391,670 		19,657 -8.3% 325.16 US$6,391,670
2020-08-24 2020-08-21
US ABIOMED Inc (ABMD)
PlS Planned sale
100 -0.0%
310.10
US$31,010 		100 -0.0% 310.10 US$31,010
2020-08-24 2020-08-21
US ABIOMED Inc (ABMD)
PlS Planned sale
4,876 -2.3%
307.96
US$1,501,613 		4,876 -2.3% 307.96 US$1,501,613
2020-08-24 2020-08-21
US ABIOMED Inc (ABMD)
PlS Planned sale
11,189 -4.9%
307.24
US$3,437,708 		11,189 -4.9% 307.24 US$3,437,708
2020-08-24 2020-08-21
US ABIOMED Inc (ABMD)
PlS Planned sale
9,235 -3.9%
306.11
US$2,826,926 		9,235 -3.9% 306.11 US$2,826,926
2020-08-24 2020-08-21
US ABIOMED Inc (ABMD)
PlS Planned sale
14,600 -5.8%
305.20
US$4,455,920 		14,600 -5.8% 305.20 US$4,455,920
2020-08-24 2020-08-20
US ABIOMED Inc (ABMD)
PlS Planned sale
2,715 -1.3%
314.13
US$852,863 		2,715 -1.3% 314.13 US$852,863
2020-08-24 2020-08-20
US ABIOMED Inc (ABMD)
PlS Planned sale
6,254 -2.8%
313.23
US$1,958,940 		6,254 -2.8% 313.23 US$1,958,940
2020-08-24 2020-08-20
US ABIOMED Inc (ABMD)
PlS Planned sale
5,596 -2.5%
312.08
US$1,746,400 		5,596 -2.5% 312.08 US$1,746,400
2020-08-24 2020-08-20
US ABIOMED Inc (ABMD)
PlS Planned sale
14,196 -5.9%
311.09
US$4,416,234 		14,196 -5.9% 311.09 US$4,416,234
2020-08-24 2020-08-20
US ABIOMED Inc (ABMD)
PlS Planned sale
27,480 -10.3%
310.09
US$8,521,273 		27,480 -10.3% 310.09 US$8,521,273
2020-08-24 2020-08-20
US ABIOMED Inc (ABMD)
PlS Planned sale
3,759 -1.4%
309.40
US$1,163,035 		3,759 -1.4% 309.40 US$1,163,035